S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   175.00 (+2.23%)
MSFT   334.90 (+-0.01%)
FB   330.76 (+2.46%)
GOOGL   2,956.95 (+0.39%)
AMZN   3,516.49 (-0.19%)
TSLA   1,067.25 (+1.47%)
NVDA   317.89 (-1.97%)
BABA   125.70 (+0.13%)
NIO   35.07 (+5.89%)
CGC   10.93 (+2.73%)
AMD   144.96 (+0.08%)
GE   98.46 (+0.93%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.45 (+1.75%)
PFE   51.41 (-0.60%)
AMC   32.03 (+3.19%)
ACB   6.57 (+2.98%)
BA   211.04 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   175.00 (+2.23%)
MSFT   334.90 (+-0.01%)
FB   330.76 (+2.46%)
GOOGL   2,956.95 (+0.39%)
AMZN   3,516.49 (-0.19%)
TSLA   1,067.25 (+1.47%)
NVDA   317.89 (-1.97%)
BABA   125.70 (+0.13%)
NIO   35.07 (+5.89%)
CGC   10.93 (+2.73%)
AMD   144.96 (+0.08%)
GE   98.46 (+0.93%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.45 (+1.75%)
PFE   51.41 (-0.60%)
AMC   32.03 (+3.19%)
ACB   6.57 (+2.98%)
BA   211.04 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   175.00 (+2.23%)
MSFT   334.90 (+-0.01%)
FB   330.76 (+2.46%)
GOOGL   2,956.95 (+0.39%)
AMZN   3,516.49 (-0.19%)
TSLA   1,067.25 (+1.47%)
NVDA   317.89 (-1.97%)
BABA   125.70 (+0.13%)
NIO   35.07 (+5.89%)
CGC   10.93 (+2.73%)
AMD   144.96 (+0.08%)
GE   98.46 (+0.93%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.45 (+1.75%)
PFE   51.41 (-0.60%)
AMC   32.03 (+3.19%)
ACB   6.57 (+2.98%)
BA   211.04 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   175.00 (+2.23%)
MSFT   334.90 (+-0.01%)
FB   330.76 (+2.46%)
GOOGL   2,956.95 (+0.39%)
AMZN   3,516.49 (-0.19%)
TSLA   1,067.25 (+1.47%)
NVDA   317.89 (-1.97%)
BABA   125.70 (+0.13%)
NIO   35.07 (+5.89%)
CGC   10.93 (+2.73%)
AMD   144.96 (+0.08%)
GE   98.46 (+0.93%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.45 (+1.75%)
PFE   51.41 (-0.60%)
AMC   32.03 (+3.19%)
ACB   6.57 (+2.98%)
BA   211.04 (+1.06%)
LON:CRW

Craneware Share Forecast, Price & News

GBX 2,395
-5.00 (-0.21%)
(As of 12/8/2021 04:37 PM ET)
Add
Compare
Today's Range
2,390
2,400
50-Day Range
2,240
2,700
52-Week Range
1,900
2,830
Volume
14,813 shs
Average Volume
36,380 shs
Market Capitalization
£850.87 million
P/E Ratio
67.66
Dividend Yield
1.15%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive CRW News and Ratings via Email

Sign-up to receive the latest news and ratings for Craneware and its competitors with MarketBeat's FREE daily newsletter.


Craneware logo

About Craneware

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; interface scripting module, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; Patient Charge Estimator to simplify the process of providing patient bill estimates for inpatient and outpatient services; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers consulting and professional services; and sales and marketing, product development, and software development services. Craneware plc was founded in 1999 and is headquartered in Edinburgh, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
350
Year Founded
N/A

Sales & Book Value

Annual Sales
£75.58 million
Cash Flow
GBX 664.34 per share
Book Value
GBX 796.70 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£850.87 million
Optionable
Not Optionable

Company Calendar

Ex-Dividend
11/19/2021
Today
12/08/2021
Dividend Payable
12/21/2021
Next Earnings (Estimated)
2/28/2022

MarketRank

Overall MarketRank

2.42 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.7Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Craneware (LON:CRW) Frequently Asked Questions

Is Craneware a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Craneware in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Craneware stock.
View analyst ratings for Craneware
or view top-rated stocks.

How has Craneware's stock been impacted by Coronavirus (COVID-19)?

Craneware's stock was trading at GBX 1,660 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRW shares have increased by 44.3% and is now trading at GBX 2,395.
View which stocks have been most impacted by COVID-19
.

When is Craneware's next earnings date?

Craneware is scheduled to release its next quarterly earnings announcement on Monday, February 28th 2022.
View our earnings forecast for Craneware
.

How often does Craneware pay dividends? What is the dividend yield for Craneware?

Craneware announced a dividend on Tuesday, September 21st. Shareholders of record on Friday, November 19th will be paid a dividend of GBX 15.50 per share on Tuesday, December 21st. This represents a dividend yield of 0.66%. The ex-dividend date is Friday, November 19th. This is a boost from Craneware's previous dividend of GBX 12. The official announcement can be seen at this link.
View Craneware's dividend history
.

Is Craneware a good dividend stock?

Craneware pays an annual dividend of GBX 0.36 per share and currently has a dividend yield of 1.15%. The dividend payout ratio of Craneware is 1.03%. This payout ratio is at a healthy, sustainable level, below 75%.
View Craneware's dividend history.

What price target have analysts set for CRW?

1 equities research analysts have issued 12 month price objectives for Craneware's stock. Their forecasts range from GBX 3,100 to GBX 3,100. On average, they expect Craneware's share price to reach GBX 3,100 in the next year. This suggests a possible upside of 29.4% from the stock's current price.
View analysts' price targets for Craneware
or view top-rated stocks among Wall Street analysts.

Who are Craneware's key executives?

Craneware's management team includes the following people:
  • Mr. Keith Neilson, Co-Founder, CEO & Exec. Director (Age 52, Pay $390.23k)
  • Mr. Craig Thomas Preston, CFO, Company Sec. & Exec. Director (Age 50, Pay $317.84k)
  • Mr. Derek William Paterson, Chief Information Officer (Age 53)
  • Mr. Eric Carter, Chief Legal Officer
  • Mr. Seth Droe, Exec. VP of Sales
  • Mr. Mark Montgomery, Chief Marketing Officer
  • Ms. Issy Urquhart, Chief People Officer
  • Ms. Karen Bowden, Exec. VP of Customer Management

What other stocks do shareholders of Craneware own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Craneware investors own include Diageo (DEO), Blue Prism Group (PRSM), accesso Technology Group (ACSO), Boeing (BA), IAMGOLD (IAG), Maxar Technologies (MAXR), McDonald's (MCD), Netflix (NFLX), PayPal (PYPL) and QUALCOMM (QCOM).

What is Craneware's stock symbol?

Craneware trades on the London Stock Exchange (LON) under the ticker symbol "CRW."

How do I buy shares of Craneware?

Shares of CRW and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Craneware's stock price today?

One share of CRW stock can currently be purchased for approximately GBX 2,395.

How much money does Craneware make?

Craneware has a market capitalization of £850.87 million and generates £75.58 million in revenue each year.

How many employees does Craneware have?

Craneware employs 350 workers across the globe.

What is Craneware's official website?

The official website for Craneware is public.craneware.com.

Where are Craneware's headquarters?

Craneware is headquartered at 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom.

How can I contact Craneware?

Craneware's mailing address is 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom. The company can be reached via phone at +44-131-5503100.


This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.